Page 248 - Read Online
P. 248

Martínez et al.                                                                                                                   Cardiomyocyte energetic changes in ischemia and arrythmogenesis

           72.  Nagoshi T, Yoshimura M, Rosano GM, Lopaschuk GD, Mochizuki S.   emergence of post-acidosis arrhythmia at the tissue level: a theoretical
               Optimization of cardiac metabolism in heart failure. Curr Pharm Des   study. Front Physiol 2017;8:195.
               2011;17:3846-53.                               94.  Kolettis T. Coronary artery disease and ventricular tachyarrhythmia:
           73.  Babalis D, Tritakis V, Floros G, Mouzarou A, Kafkas N, Bampali K,   pathophysiology and treatment. Curr Opin Pharmacol 2013;13:210-7.
               Mertzanos G. Effects of ranolazine on left ventricular diastolic and   95.  Thackeray JT, Beanlands RS,  DaSilva JN.  Altered sympathetic
               systolic function in patients with chronic coronary disease and stable   nervous system signaling in the diabetic heart: emerging targets for
               angina. Hellenic J Cardiol 2015;56:237-41.        molecular imaging. Am J Nucl Med Mol Imaging 2012;2:314-34.
           74.  Burkhoff D, Weiss RG, Schulman  SP, Kalil-Filho  R, Wannenburg   96.  Oikonomidis DL, Tsalikakis DG, Baltogiannis  GG,  Tzallas  AT,
               T,  Gerstenblith  G.  Influence  of  metabolic  substrate  on  rat  heart   Xourgia X, Agelaki MG, Megalou AJ, Fotopoulos A, Papalois A,
               function and metabolism at different coronary flows. Am J Physiol   Kyriakides ZS, Kolettis TM. Endothelin-B receptors and ventricular
               1991;261:H741-50.                                 arrhythmogenesis in the rat model of acute myocardial  infarction.
           75.  Sabbah  HN, Gupta  RC, Rastogi  S, Wang  M. Dysregulation  of   Basic Res Cardiol 2009;105:235-45.
               mitochondria fission and fusion proteins in explanted failure human   97.  Francis Stuart S, De Jesus N, Lindsey M, Ripplinger C. The crossroads
               hearts. J Heart Lung Transplant 2011;30:S137.     of  inflammation,  fibrosis,  and  arrhythmia  following  myocardial
           76.  Carolo dos Santos K, Pereira Braga C, Octavio Barbanera P, Seiva   infarction. J Mol Cell Cardiol 2016;91:114-22.
               FR, Fernandes Junior A, Fernandes AA. Cardiac energy metabolism   98.  Skovsted GF, Kruse LS, Berchtold  LA, Grell AS, Warfvinge
               and oxidative stress biomarkers in diabetic rat treated with resveratrol.   K, Edvinsson L. Myocardial  ischemia-reperfusion  enhances
               PLoS One 2014;9:e102775.                          transcriptional  expression  of endothelin-1 and vasoconstrictor ETB
           77.  Maulucci G, Daniel B, Cohen O, Avrahami Y, Sasson S. Hormetic   receptors via the protein kinase MEK-ERK1/2 signaling pathway in
               and regulatory effects of lipid peroxidation mediators in pancreatic   rat. PLoS One 2017;12:e0174119.
               beta cells. Mol Aspects Med 2016;49:49-77.     99.  Streitner F, Kuschyk J, Veltmann C, Ratay D, Schoene N, Streitner
           78.  Ayala A, Muñoz MF, Argüelles S. Lipid peroxidation: production,   I, Brueckmann  M, Schumacher  B, Borggrefe  M, Wolpert  C. Role
               metabolism,  and  signaling  mechanisms  of malondialdehyde  and   of  proinflammatory  markers  and  NT-proBNP  in  patients  with  an
               4-hydroxy-2-nonenal. Oxid Med Cell Longev 2014;2014:360438.   implantable cardioverter-defibrillator and an electrical storm. Cytokine
           79.  Gruzdeva O, Uchasova E, Dyleva Y, Belik E, Kashtalap V, Barbarash   2009;47:166-72.
               O. Relationship between free fatty acids, insulin resistance markers,   100. Maradit-Kremers H, Crowson CS, Nicola PJ, Ballman  KV, Roger
               and  oxidized  lipoproteins  in myocardial  infarction  and acute  left   VL, Jacobsen SJ, Gabriel SE. Increased unrecognized coronary heart
               ventricular failure. Diabetes Metab Syndr Obes 2013;6:103-11.  disease and sudden deaths in rheumatoid arthritis: a population-based
           80.  Roy VK, Kumar A, Joshi P, Arora J, Ahanger AM. Plasma free fatty   cohort study. Arthritis Rheum 2005;52:402-11.
               acid concentrations as a marker for acute myocardial infarction. J Clin   101. Downar E, Janse MJ, Durrer D. The effects of acute coronary artery
               Diagn Res 2013;7:2432-4.                          occlusion  on subepicardial  transmembrane  potentials  in  the  intact
           81.  Ma P, Han L, Lv Z, Chen W, Hu H, Tu J, Zhou X, Liu SM. In-hospital   porcine heart. Circulation 1977;56:217-24.
               free fatty acids levels predict the severity of myocardial ischemia of   102. Biktashev  VN, Biktasheva  IV, Sarvazyan  NA. Evolution  of spiral
               acute coronary syndrome. BMC Cardiovasc Disord 2016;16:29.  and scroll waves of excitation in a mathematical model of ischaemic
           82.  Styskal J, Van Remmen  H, Richardson A, Salmon AB. Oxidative   border zone. PLoS One 2011;6:e24388.
               stress and diabetes: what can we learn about insulin resistance from   103. Solovyova O, Katsnelson L, Kohl P, Panfilov A, Tsaturyan A, Tsyvian
               antioxidant mutant mouse models? Free Radic Biol Med 2012;52:46-  P. Mechano-electric heterogeneity of the myocardium as a paradigm
               58.                                               of its function. Prog Biophys Mol Biol 2016;120:249-54.
           83.  Abel ED, O’Shea KM, Ramasamy R. Insulin resistance: metabolic   104. Robbers LF, Delewi R, Nijveldt  R, Hirsch A, Beek AM, Kemme
               mechanisms and consequences in the heart. Arterioscler Thromb Vasc   MJ, van Beurden Y, van der Laan AM, van der Vleuten PA, Tio RA,
               Biol 2012;32:2068-76.                             Zijlstra F, Piek JJ, van Rossum AC. Myocardial infarct heterogeneity
           84.  Drosatos K, Schulze PC. Cardiaclipotoxicity: molecular pathways and   assessment by late gadolinium enhancement cardiovascular magnetic
               therapeutic implications. Curr Heart Fail Rep 2013;10:109-21.  resonance imaging shows predictive value for ventricular arrhythmia
           85.  Park TS, Goldberg IJ. Sphingolipids, lipotoxic cardiomyopathy, and   development  after acute  myocardial  infarction.  Eur Heart J
               cardiac failure. Heart Fail Clin 2012;8:633-41.   Cardiovasc Imaging 2013;14:1150-8.
           86.  Steggall A, Mordi IR, Lang CC. Targeting metabolic modulation and   105. Pertsov AM, Davidenko JM, Salomonsz R, Baxter WT, Jalife J. Spiral
               mitochondrial dysfunction in the treatment of heart failure. Diseases   waves of excitation  underlie  reentrant  activity  in  isolated  cardiac
               2017;5:14.                                        muscle. Circ Res 1993;72:631-50.
           87.  Deo R, Albert CM. Epidemiology and genetics  of sudden cardiac   106. Oliver MF.  Control of free fatty acids during acute myocardial
               death. Circulation 2012;125:620-37.               ischaemia. Heart 2010;96:1883-4.
           88.  Hayashi M, Shimizu W, Albert CM. The spectrum of epidemiology   107. Tse G. Mechanisms of cardiac arrhythmias. J Arrhythm 2016;32:75-
               underlying sudden cardiac death. Circ Res 2015;116:1887-906.  81.
           89.  Bhar-Amato  J, Davies W,  Agarwal  S. Ventricular  arrhythmia   108. Oliver MF, Kurien VA, Greenwood TW. Relation  between serum
               after  acute  myocardial  infarction:  “the  perfect  storm”.  Arrhythm   free fatty acids and arrhythmias  and death after acute  myocardial
               Electrophysiol Rev 2017;6:134-9.                  infarction. Lancet 1968;1:710-4.
           90.  Kalogeris  T, Baines  CP, Krenz M, Korthuis RJ. Cell  biology  of   109. Tansey MJ, Opie LH. Relation  between plasma free fatty acids
               ischemia/reperfusion injury. Int Rev Cell Mol Biol 2012;298:229-317.  and  arrhythmias  within  the  first  twelve  hours  of  acute  myocardial
           91.  Gewirtz H, Dilsizian V. Myocardial viability: survival mechanisms   infarction. Lancet 1983;2:419-22.
               and molecular imaging targets in acute and chronicischemia. Circ Res   110. Ouven X, Charles MA, Desnos M, Ducimetiere P. Circulating non-
               2017;120:1197-212.                                esterified fatty acid level as a predictive risk factor for sudden death in
           92.  Baumeister P, Quinn TA. Altered calcium handling and ventricular   the population. Circulation 2001;104:756-61.
               arrhythmias in acute ischemia. Clin Med Insights Cardiol 2016;10:61-9.  111. Yang KC, Kyle JW, Makielski JC, Dudley SC. Mechanisms of sudden
           93.  Bai  J, Yin  R,  Wang  K, Zhang  H. Mechanisms  underlying  the   cardiac death: oxidants and metabolism. Circ Res 2015;116:1937-55.

            240                                                                                                                    Vessel Plus ¦ Volume 1 ¦ December 28, 2017
   243   244   245   246   247   248   249   250   251   252   253